
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.510 | 4.510 | 0.000 |
Shares | 95.930 | 95.930 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.006 | 19.606 |
Price to Book | 5.550 | 3.867 |
Price to Sales | 2.804 | 2.210 |
Price to Cash Flow | 17.668 | 14.698 |
Dividend Yield | 1.283 | 1.499 |
5 Years Earnings Growth | 7.533 | 9.831 |
Number of long holdings: 32
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 7.71 | 391.02 | -0.26% | |
Gilead | US3755581036 | 7.37 | 112.97 | +0.36% | |
Eli Lilly | US5324571083 | 7.25 | 732.58 | +0.08% | |
Amgen | US0311621009 | 6.32 | 287.71 | +0.74% | |
Lonza Group | CH0013841017 | 5.84 | 567.00 | -0.46% | |
Alnylam | US02043Q1076 | 5.39 | 446.51 | -1.29% | |
Boston Scientific | US1011371077 | 5.36 | 105.50 | -0.24% | |
Neurocrine | US64125C1099 | 4.87 | 139.60 | +0.48% | |
AstraZeneca | GB0009895292 | 4.66 | 11,790.0 | -0.17% | |
AbbVie | US00287Y1091 | 4.44 | 210.40 | +1.19% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Nomura Taiwan Superior Equity Fund | 27.87B | 7.54 | 27.40 | 18.85 | ||
Nomura Global Equity Fund TWD | 12.64B | 1.64 | 15.91 | 10.53 | ||
Nomura Taiwan Small Cap Fund | 10.47B | 4.67 | 27.33 | 19.09 | ||
Nomura Taiwan Growth Fund | 3.1B | 6.72 | 29.95 | 18.59 | ||
Nomura Taiwan Growth Selection Fund | 2.57B | 7.22 | 31.45 | 18.09 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review